Literature DB >> 18401547

TIM-3 polymorphisms in type 1 diabetes families.

Patrick Brück1, Elizabeth Ramos-Lopez2, Wiebke Bartsch2, Angelika Böhme1, Klaus Badenhoop3.   

Abstract

TIM-3 is a transmembrane protein preferentially expressed on differentiated Th1 cells, which play a role in Th1-mediated diseases including type 1 diabetes. We investigated the role of the rs10515746 (A/C), rs1036199 (A/C), and rs10053538 (A/C) single nucleotide polymorphisms (SNPs) within the TIM-3 gene in 186 German type 1 diabetes families (558 individuals) and its interaction with human leukocyte antigen (HLA) high-risk haplotypes DQ2(DQA*0501-DQB*0201)-DQ8 (DQA*0301-DQB*0302). Alleles A, C, and A of the rs10515746 (A/C), rs1036199 (A/C), and rs10053538 (A/C) SNPs were found in a frequency of 20.4%, 19.0%, and 4.2%, respectively. Transmission analysis of these polymorphisms did not show any significant difference. Although in patients with HLA DQx/x (neither HLA DQ2 nor DQ8) an undertransmission of allele A (14.3% vs. 85.7%) of the rs10053538 (A/C) SNP and an overtransmission of allele A (66.7% vs. 33.3%) of the rs10515746 (A/C) SNP was observed, these associations did not remain statistically significant after correction for multiple comparisons. Although we found no association of TIM-3 with type 1 diabetes in the German population, we cannot discard a possible association in a larger size.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18401547     DOI: 10.1007/s10038-008-0286-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  26 in total

Review 1.  Tolerance and autoimmunity.

Authors:  T Kamradt; N A Mitchison
Journal:  N Engl J Med       Date:  2001-03-01       Impact factor: 91.245

2.  PBAT: tools for family-based association studies.

Authors:  Christoph Lange; Dawn DeMeo; Edwin K Silverman; Scott T Weiss; Nan M Laird
Journal:  Am J Hum Genet       Date:  2004-02       Impact factor: 11.025

3.  Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes.

Authors:  R Bergholdt; P Ghandil; J Johannesen; O P Kristiansen; I Kockum; H Luthman; K S Rønningen; J Nerup; C Julier; F Pociot
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

4.  Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.

Authors:  Ana C Anderson; David E Anderson; Lisa Bregoli; William D Hastings; Nasim Kassam; Charles Lei; Rucha Chandwaskar; Jozsef Karman; Ee W Su; Mitsuomi Hirashima; Jeffrey N Bruce; Lawrence P Kane; Vijay K Kuchroo; David A Hafler
Journal:  Science       Date:  2007-11-16       Impact factor: 47.728

5.  Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease.

Authors:  H Donner; J Braun; C Seidl; H Rau; R Finke; M Ventz; P G Walfish; K H Usadel; K Badenhoop
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

6.  Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele.

Authors:  G Morahan; D Huang; S I Ymer; M R Cancilla; K Stephen; P Dabadghao; G Werther; B D Tait; L C Harrison; P G Colman
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

7.  Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules.

Authors:  M A Pani; J Van Autreve; B J Van der Auwera; F K Gorus; K Badenhoop
Journal:  Diabetologia       Date:  2002-07-06       Impact factor: 10.122

8.  Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations.

Authors:  C T Falk; P Rubinstein
Journal:  Ann Hum Genet       Date:  1987-07       Impact factor: 1.670

Review 9.  Lymphokine production by human T cells in disease states.

Authors:  S Romagnani
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

10.  T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis.

Authors:  Mohsen Khademi; Zsolt Illés; Alexander W Gielen; Monica Marta; Naruhiko Takazawa; Claire Baecher-Allan; Lou Brundin; Jan Hannerz; Claes Martin; Robert A Harris; David A Hafler; Vijay K Kuchroo; Tomas Olsson; Fredrik Piehl; Erik Wallström
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

View more
  9 in total

1.  T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer.

Authors:  Danian Tong; Yujia Zhou; Wei Chen; Yang Deng; Lei Li; Zhenyi Jia; Dachuan Qi
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

2.  DNA demethylation of the TIM-3 promoter is critical for its stable expression on T cells.

Authors:  F-C Chou; C-C Kuo; H-Y Chen; H-H Chen; H-K Sytwu
Journal:  Genes Immun       Date:  2016-02-18       Impact factor: 2.676

Review 3.  Activation pathways that drive CD4+ T cells to break tolerance in autoimmune diseases.

Authors:  Sai Harsha Krovi; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2022-02-10       Impact factor: 10.983

4.  TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) Gene Polymorphisms and Risk of Multiple Sclerosis.

Authors:  Esmat Yaghoobi; Saeed Abedian; Omid Babani; Maryam Izad
Journal:  Iran J Public Health       Date:  2016-05       Impact factor: 1.429

Review 5.  Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis.

Authors:  David H Wagner
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-23       Impact factor: 5.555

6.  TIM-3 genetic variants and risk of Behçet disease in the Iranian population.

Authors:  Mitra Ataei; Farinaz Behfarjam; Zohreh Jadali
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

Review 7.  Tim-3 expression and its role in hepatocellular carcinoma.

Authors:  Feifei Liu; Yanning Liu; Zhi Chen
Journal:  J Hematol Oncol       Date:  2018-10-11       Impact factor: 17.388

8.  TIM-3 rs1036199 polymorphism increases susceptibility to autoimmune diseases: evidence based on 4200 subjects.

Authors:  Rongzeng Liu; Xing Wang; Xiafei Chen; Shengnan Wang; Heqian Zhang
Journal:  Biosci Rep       Date:  2018-11-23       Impact factor: 3.840

9.  TIM-3 Genetic Variants Are Associated with Altered Clinical Outcome and Susceptibility to Gram-Positive Infections in Patients with Sepsis.

Authors:  Caspar Mewes; Tessa Alexander; Benedikt Büttner; José Hinz; Ayelet Alpert; Aron-F Popov; Michael Ghadimi; Tim Beißbarth; Mladen Tzvetkov; Marian Grade; Michael Quintel; Ingo Bergmann; Ashham Mansur
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.